hepatoma

简明释义

英[ˌhepəˈtəʊmə]美[ˌhepəˈtoʊmə]

n. 肝癌；[肿瘤] 肝细胞瘤（尤指恶性肿瘤）

复 数 h e p a t o m a s 或 h e p a t o m a t a

英英释义

单词用法

同义词

反义词

例句

1.They are all important in the carcinogenesis of hepatoma.

这些基因在肝癌的发病中可能起着非常重要的作用。

2.Objective: to investigate the toxic reactions and clinical effect of Emulsion in the treatment of intermediate stage hepatoma treated with TACE.

目的：评价榄香烯乳在肝动脉化疗栓塞治疗中期肝癌中的毒性反应和临床疗效。

3.Objective: to investigate the effect on growth of hepatoma cell line 3b by berberine and the mechanism.

目的：观察黄连素对肝癌细胞株3b生长的影响，并且探讨其作用的机理。

4.Objective to study the nursing cooperation on the transarterial intervention experiment of transplantation hepatoma model on rats.

目的总结大鼠移植性肝癌模型血管介入的配合经验。

5.Objective: to study the effects of splenectomy on the growth of intrahepatic implanted hepatoma in the rats with cirrhosis.

目的：探讨脾切除对肝硬变大鼠移植型肝癌的影响。

6.Under light microscope, the cellular nuclei of hepatoma were enlarged, and the nuclear membranes thickened.

光镜下肝癌胞核普遍增大、核膜增厚、核仁明显。

7.Objective To probe into perioperative nursing care for interventional therapy of hepatoma.

目的：探讨肝癌介入治疗围手术期的护理。

8.A biopsy confirmed the presence of hepatoma (肝癌) in the liver.

活检确认肝脏中存在hepatoma（肝癌）。

9.Treatment options for hepatoma (肝癌) may include surgery, chemotherapy, and targeted therapy.

治疗hepatoma（肝癌）的选择可能包括手术、化疗和靶向治疗。

10.The patient was diagnosed with hepatoma (肝癌) after several months of unexplained weight loss.

经过几个月的无缘无故的体重减轻，患者被诊断为hepatoma（肝癌）。

11.Doctors recommend regular screenings for those at risk of hepatoma (肝癌).

医生建议对有风险的人定期筛查hepatoma（肝癌）。

12.Symptoms of hepatoma (肝癌) can include jaundice and abdominal pain.

hepatoma（肝癌）的症状可能包括黄疸和腹痛。

作文

Hepatoma, also known as liver cancer, is a type of malignant tumor that originates in the liver. It is one of the most common types of liver cancer and often arises in individuals with chronic liver diseases such as hepatitis B or C infection and cirrhosis. Understanding hepatoma is crucial for early diagnosis and effective treatment. In recent years, the incidence of hepatoma has been on the rise, especially in regions where hepatitis infections are prevalent. The symptoms of hepatoma can be vague and may include weight loss, loss of appetite, abdominal pain, and jaundice. These symptoms often lead to a delayed diagnosis, which can severely impact the prognosis. Therefore, awareness of the risk factors associated with hepatoma is essential. Risk factors include chronic viral hepatitis, excessive alcohol consumption, obesity, and exposure to aflatoxins. Diagnosis of hepatoma typically involves imaging studies such as ultrasound, CT scans, or MRI, along with blood tests to check for liver function and tumor markers. One of the most important tumor markers for hepatoma is alpha-fetoprotein (AFP), which can be elevated in individuals with this condition. Early detection of hepatoma significantly improves the chances of successful treatment. Treatment options for hepatoma vary depending on the stage of the disease. For early-stage hepatoma, surgical resection or liver transplantation may be viable options. However, for advanced stages, treatments may include radiofrequency ablation, transarterial chemoembolization, or targeted therapies. Recently, immunotherapy has also emerged as a promising treatment avenue for hepatoma, offering hope to patients with advanced disease. Prevention plays a vital role in combating hepatoma. Vaccination against hepatitis B, regular screening for high-risk individuals, and lifestyle modifications such as maintaining a healthy weight and limiting alcohol intake can help reduce the risk of developing hepatoma. Public health initiatives aimed at increasing awareness about hepatitis and liver health are crucial in decreasing the incidence of this aggressive cancer. In conclusion, hepatoma (肝癌) is a serious health concern that requires attention from both the medical community and the public. With rising rates of liver disease globally, understanding the risk factors, symptoms, and treatment options for hepatoma (肝癌) is essential for improving patient outcomes. By focusing on prevention and early detection, we can work towards reducing the burden of this disease and enhancing the quality of life for those affected by it.

肝癌，也被称为肝肿瘤，是一种起源于肝脏的恶性肿瘤。它是最常见的肝癌类型之一，通常出现在慢性肝病患者中，如乙型或丙型肝炎感染和肝硬化。理解肝癌对于早期诊断和有效治疗至关重要。近年来，肝癌的发病率有所上升，尤其是在乙型肝炎感染较为普遍的地区。肝癌的症状可能模糊不清，包括体重减轻、食欲丧失、腹痛和黄疸。这些症状通常导致延迟诊断，严重影响预后。因此，了解与肝癌相关的风险因素至关重要。风险因素包括慢性病毒性肝炎、过量饮酒、肥胖以及接触黄曲霉毒素。肝癌的诊断通常涉及超声、CT扫描或MRI等影像学检查，以及血液检测以检查肝功能和肿瘤标志物。肝癌最重要的肿瘤标志物之一是甲胎蛋白（AFP），在患有此疾病的人群中可能会升高。早期发现肝癌显著提高成功治疗的机会。肝癌的治疗方案因疾病的阶段而异。对于早期肝癌，外科切除或肝移植可能是可行的选择。然而，对于晚期肝癌，治疗可能包括射频消融、经动脉化疗栓塞或靶向治疗。最近，免疫疗法也成为肝癌治疗的新兴希望，为晚期患者提供了希望。预防在对抗肝癌方面发挥着至关重要的作用。接种乙型肝炎疫苗、定期筛查高风险人群以及生活方式的改变，例如保持健康体重和限制酒精摄入，可以帮助降低肝癌的风险。旨在提高公众对肝炎和肝脏健康认识的公共卫生倡议对于减少这一侵袭性癌症的发生至关重要。总之，肝癌（hepatoma）是一个严重的健康问题，需要医学界和公众的关注。随着全球肝病发病率的上升，理解肝癌的风险因素、症状和治疗选择对于改善患者预后至关重要。通过关注预防和早期发现，我们可以努力减少这一疾病的负担，提高受其影响者的生活质量。